Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

NCT00056524 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Stroke
Parkinson's Disease
Traumatic Brain Injury

Interventions

DRUG: AVP-923

Sponsor

Avanir Pharmaceuticals